Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated with Immunotherapy

Pseudoprogression has been observed in patients with various tumor types treated with immunotherapy. However, the frequency of pseudoprogression is unknown in gastrointestinal malignancies. Metastatic colorectal cancer (mCRC) and advanced pancreatic ductal adenocarcinoma (PDAC) patients who progress...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother
Glavni autori: Parseghian, Christine M., Patnana, Madhavi, Bhosale, Priya, Hess, Kenneth R., Shih, Ya-Chen Tina, Kim, Bumyang, Kopetz, Scott, Overman, Michael J., Varadhachary, Gauri R., Javle, Milind, Naing, Aung, Piha-Paul, Sarina, Hong, David, Le, Hung, Subbiah, Vivek, Pant, Shubham
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028046/
https://ncbi.nlm.nih.gov/pubmed/29668571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000222
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items